FocalTherics™ Reports Third Quarter 2026 Financial Results
Globe Newswire•05/11/2026•16:05 ET
0
Key Highlights
- ➤Q3 revenue $9.8 million, up 26% year-over-year
- ➤2026 revenue guidance narrowed to $50.0-$52.0 million
- ➤U.S. procedure volume increased 32% year-over-year in Q3
- ➤Focal One installed base reached 192 systems globally
- ➤Gross margin rose to 51.4% from 46.6% year-over-year
Expert Statements
Ryan Rhodes, CEO of FocalTherics
“We demonstrated steady commercial momentum in the third quarter, highlighted by expanding adoption across multiple new regions and additional system sales in the United States, Turkey, Mexico, and France.”
Ryan Rhodes, CEO of FocalTherics
“U.S. procedure volumes accelerated year-over-year to 32% for the third quarter of 2026, compared to 15% in 2025.”
Ryan Rhodes, CEO of FocalTherics
“Driven by our sustained commercial traction, accelerating technology adoption, and our focus on our HIFU opportunity, we remain highly confident in our growth strategy and on the opportunity ahead as we close out the year.”
45% Revenue Increase and 44% Growth in U.S. Procedure Volume Year-to-date
45% Revenue Increase and 44% Growth in U.S. Procedure Volume Year-to-date
Get started
Create a free account to read the full story.